News Muncher - searching for market

markets

Over 650 million adults globally suffer from obesity, and this number is only expected to rise. India’s rising players in the GLP-1 market Indian pharmaceutical giants like Sun Pharma, Cipla, Dr. Reddy’s, Natco Pharma, and Lupin are in a fierce race to bring obesity drugs to the Indian market. Cipla: Entering the market with generics Cipla, one of India’s most …

Stock market today: Nifty 50, Sensex surge over 1% on gains in RIL, Airtel & pharma stocks

Stock market today: Despite heightening geopolitical tensions, the Indian stock market made a strong recovery on Friday, November 29 as strong support from heavyweights such as Bharti Airtel, Reliance Industries, and ICICI Bank helped the frontline indices finish the last trading day of November in positive territory. Sectoral Performance: Pharma shines, realty lags Among sectoral indices, Nifty Pharma emerged as …

Stock Market

Market

The stock markets are facing a tough week as Sensex and Nifty dropped close to 1.5% on Wednesday. The company reported an 8% growth in its standalone net profit for the quarter ending September 2024, reaching Rs 1,010 crore. TATA POWER Tata Power’s stock may see activity after the company announced the commissioning of a 126 MW floating solar project …

Indian pharma companies have long been key providers of generic medicines to the US market, accounting for 47% of all generic prescriptions in 2022, according to a recent report by the IQVIA Institute. Branded for growth Mankind Pharma Ltd, which earns 91% of its revenue from its domestic business and has a prescriber penetration rate of almost 84% as of …

Top Gainers and Losers Today: A Snapshot of the Nifty and Sensex Market

Top gainers and losers today in the Indian stock market show significant movements. The Nifty index experienced a decline of 0.56%, with top gainers including Cipla, Larsen & Toubro, Dr. Reddy's Laboratories, Oil & Natural Gas Corporation, and Hero Motocorp. Conversely, Tech Mahindra, HCL Technologies, Tata Consultancy Services, Infosys, and Wipro were among the top losers. In the BSE, Cipla, …

Markets

Buy or sell stocks: Despite global market sentiments, the Indian stock market snapped a six-session winning streak on Friday. Sumeet Bagadia's stocks to buy today Sumeet Bagadia, Executive Director at Choice Broking, believes the overall trend of the Indian stock market is bullish, and the Nifty 50 index is poised to touch 26,900 despite the 50-stock index closing red on …

Here’s a quick look at stocks likely to be in focus in today's trade. AU Small Finance Bank: On Tuesday, WestBridge Capital divested a 1.5 percent stake in AU Small Finance Bank, amounting to ₹736 crore through open market transactions. As per BSE's bulk deal data, WestBridge Capital, via its affiliate WestBridge AIF I, sold 1,08,95,517 shares at an average …

Buy or sell stocks today: The Indian domestic stock market indices witnessed strong gains on Monday, August 26. Vaishali Parekh's stocks to buy today Vaishali Parekh, vice president of technical research at Prabhudas Lilladher, says Nifty's slow and steady gained strength has crossed the 25,000 zone, indicating strength with a strong maintained bias. Regarding stocks to buy today, Vaishali Parekh …

Stock Market today: Cipla share price that has gained more than 24% year to date is trading near 52 week highs it scaled on Friday. Cipla had reported strong Q1 performance with net profit rising 17% YoY largely helped by improved operating performance as reported Ebitda grew 14% though revenue grew t a slower pace of 7% year-on-year. The same …

Cipla net soars 43% on growth in India, other key markets

Buy or sell stocks: Despite weakness in Asian stock market after the soft US economic data, Indian stock market finished higher on the weekend session last week. Asked about stocks to buy when stock market opens after the weekend holidays, Sumeet Bagadia of Choice Broking recommended three stocks to buy on Monday — Hindustan Unilever Ltd, Polycab and Cipla. Sumeet …

India is looking at greater market access for its pharmaceutical products in Australia as its top drugmakers are set to visit the country in the first week of February, News18.com has learnt. The tour is a part of the pharmaceutical supply chain resilience initiative following India’s free trade agreement with Australia. All the top drugmakers of India such as Sun …

Roche launches COVID-19 'Antibody Cocktail' in India at Rs 59,750 per dose; Cipla to market drug in country

Covid: Roche's antibody cocktail launched in India at Rs 59,750 per patient, Cipla to market it